{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:46:06Z","timestamp":1788173166265,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","immunology.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.iac.2016.06.011","type":"journal-article","created":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T02:16:02Z","timestamp":1475547362000},"page":"735-747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Mechanisms of Benefit with Aspirin Therapy in Aspirin-Exacerbated Respiratory Disease"],"prefix":"10.1016","volume":"36","author":[{"given":"Jennifer","family":"Hill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trever","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Katial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.iac.2016.06.011_bib1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0049-3848(03)00379-7","article-title":"The mechanism of action of aspirin","volume":"110","author":"Vane","year":"2003","journal-title":"Thromb Res"},{"key":"10.1016\/j.iac.2016.06.011_bib2","first-page":"189","article-title":"Anaphylaxieet idiosyncrasie","volume":"30","author":"Widal","year":"1922","journal-title":"Presse Med"},{"key":"10.1016\/j.iac.2016.06.011_bib3","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-68-5-975","article-title":"Intolerance to aspirin: clinical studies and consideration of its pathogenesis","volume":"68","author":"Samter","year":"1968","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.iac.2016.06.011_bib4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0091-6749(80)90143-8","article-title":"Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges","volume":"66","author":"Stevenson","year":"1980","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.011_bib5","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0091-6749(84)90361-0","article-title":"Aspirin-sensitive rhinosinusitis asthma: a double-blind cross-over study of treatment with aspirin","volume":"73","author":"Stevenson","year":"1984","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.011_bib6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1081-1206(10)61803-0","article-title":"Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease","volume":"90","author":"Berges-Gimeno","year":"2003","journal-title":"Ann\u00a0Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2016.06.011_bib7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1067\/mai.2003.7","article-title":"Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease","volume":"111","author":"Berges-Gimeno","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.011_bib8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev.physiol.010908.163114","article-title":"Aspirin-sensitive respiratory disease","volume":"71","author":"Farooque","year":"2009","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.iac.2016.06.011_bib9","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1067\/mai.2003.1487","article-title":"Aspirin-induced asthma: advances in pathogenesis, diagnosis and management","volume":"111","author":"Szczeklik","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.011_bib10","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jaci.2006.07.024","article-title":"Clinical and pathologic perspectives on aspirin sensitivity and asthma","volume":"118","author":"Stevenson","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.011_bib11","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1164\/ajrccm.154.6.8970343","article-title":"Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics","volume":"154","author":"Szczeklik","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2016.06.011_bib12","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1164\/ajrccm\/143.5_Pt_1.1025","article-title":"Urinary leukotrienes E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects","volume":"143","author":"Christie","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.iac.2016.06.011_bib13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1183\/09031936.93.05060693","article-title":"Urinary leukotrienes E4 in bronchial asthma","volume":"5","author":"Smith","year":"1992","journal-title":"Eur Respir J"},{"key":"10.1016\/j.iac.2016.06.011_bib14","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1164\/ajrccm.149.4.8143059","article-title":"Eicosanoids in bronchoalveolar lavage fluid of aspirin intolerant patients with asthma after aspirin challenge","volume":"149","author":"Sladek","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2016.06.011_bib15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1164\/rccm.2101021","article-title":"Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma","volume":"166","author":"Antczak","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2016.06.011_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1164\/ajrccm\/145.1.65","article-title":"Release of peptide leukotrienes into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients","volume":"145","author":"Picado","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.iac.2016.06.011_bib17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1164\/ajrccm.153.1.8542168","article-title":"Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects","volume":"153","author":"Nasser","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.iac.2016.06.011_bib18","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1172\/JCI620","article-title":"Overexpression of leukotrienes C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma","volume":"101","author":"Cowburn","year":"1998","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.iac.2016.06.011_bib19","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJMoa013508","article-title":"Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis","volume":"347","author":"Sousa","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iac.2016.06.011_bib20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0091-6749(99)70324-6","article-title":"Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses","volume":"104","author":"Daffern","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.011_bib21","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jaci.2010.06.036","article-title":"The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases","volume":"126","author":"Katial","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.011_bib22","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0091-6749(95)70298-9","article-title":"Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis","volume":"96","author":"Hamilos","year":"1995","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.011_bib23","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1365-2222.2005.02316.x","article-title":"Nasal biomarker profiles in acute and chronic rhinosinusitis","volume":"35","author":"Riechelmann","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2016.06.011_bib24","first-page":"182090","article-title":"Interleukin-4 in the generation of AERD phenotype: implications for molecular mechanisms driving therapeutic benefit of aspirin desensitization","volume":"2012","author":"Steinke","year":"2012","journal-title":"J\u00a0Allergy (Cairo)"},{"key":"10.1016\/j.iac.2016.06.011_bib25","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1164\/ajrccm.151.5.7735581","article-title":"The effect of aspirin desensitization on urinary leukotriene E4 concentrations in aspirin-sensitive asthma","volume":"151","author":"Nasser","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2016.06.011_bib26","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1182\/blood.V97.6.1742","article-title":"Selective inhibition of interleukin-4 gene expression in human T\u00a0cells by aspirin","volume":"97","author":"Cianferoni","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.iac.2016.06.011_bib27","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jaci.2009.07.031","article-title":"Modulation by aspirin of nuclear phospho-signal transducer and activator of transcription 6 expression: possible role in therapeutic benefit associated with aspirin desensitization","volume":"124","author":"Steinke","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2016.06.011_bib28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaci.2014.07.031","article-title":"Prostaglandin D2: a dominant mediator of aspirin-exacerbated respiratory disease","volume":"135","author":"Cahill","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.011_bib29","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1056\/NEJMcibr1514013","article-title":"Aspirin-exacerbated respiratory disease\u2014new prime suspects","volume":"374","author":"Laidlaw","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iac.2016.06.011_bib30","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jaci.2009.04.020","article-title":"Leukotriene E4: perspective on the forgotten mediator","volume":"124","author":"Lee","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.011_bib31","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/ajrccm\/140.1.148","article-title":"Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma","volume":"140","author":"Arm","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.iac.2016.06.011_bib32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1084\/jem.193.1.123","article-title":"T\u00a0helper cell type 2 cytokines coordinately regulate immunoglobulin E-dependent cysteinyl leukotriene production by human cord blood-derived mast cells: profound induction of leukotriene C4 synthase expression by interleukin 4","volume":"193","author":"Hsieh","year":"2001","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.iac.2016.06.011_bib33","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0091-6749(95)70002-1","article-title":"Inhibition of monocyte leukotriene B4 production after aspirin desensitization","volume":"96","author":"Juergens","year":"1995","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.011_bib34","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1067\/mai.2003.1387","article-title":"A\u00a0controlled study of 9a,11b-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge","volume":"111","author":"Bochenek","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.011_bib35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1084\/jem.193.2.255","article-title":"Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2","volume":"193","author":"Hirai","year":"2001","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.iac.2016.06.011_bib36","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.4049\/jimmunol.1500905","article-title":"Aspirin-exacerbated respiratory disease involves a cysteinyl leukotriene-driven IL-33- mediated mast cell activation pathway","volume":"195","author":"Liu","year":"2015","journal-title":"J\u00a0Immunol"},{"issue":"5","key":"10.1016\/j.iac.2016.06.011_bib37","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.jaci.2015.10.020","article-title":"Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease","volume":"137","author":"Buchheit","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.011_bib38","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1165\/rcmb.2006-0252OC","article-title":"Concordant modulation of cysteinyl leukotriene receptor expression by IL-4 and IFN-\u03b3 on peripheral immune cells","volume":"36","author":"Early","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.iac.2016.06.011_bib39","doi-asserted-by":"crossref","first-page":"6536","DOI":"10.4049\/jimmunol.163.12.6536","article-title":"STAT6-dependent and -independent pathways for IL-4 production","volume":"163","author":"Kaplan","year":"1999","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.iac.2016.06.011_bib40","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.molimm.2011.01.007","article-title":"IL-4 and IL-13 suppress prostaglandins production in human follicular dendritic cells by repressing COX-2 and mPGES-1 expression through JAK1 and STAT6","volume":"48","author":"Cho","year":"2011","journal-title":"Mol Immunol"},{"key":"10.1016\/j.iac.2016.06.011_bib41","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.intimp.2012.02.012","article-title":"STAT6 and JAK1 are essential for IL-4 mediated suppression of prostaglandin production in human follicular dendritic cells: opposing roles of phosphorylated and unphosphorylated STAT6","volume":"12","author":"Cho","year":"2012","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.iac.2016.06.011_bib42","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.4049\/jimmunol.168.3.1428","article-title":"Aspirin and salicylates inhibit the IL-4 and IL-13 induced activation of STAT6","volume":"168","author":"Perez","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.iac.2016.06.011_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2015.11.038","article-title":"Non-steroidal antiinflammatory induced inhibition of STAT-6 phosphorylation in aspirin exacerbated respiratory disease","author":"Katial","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2016.06.011_bib44","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jaci.2013.05.008","article-title":"Prominent role of IFN-\u03b3 in patients with aspirin-exacerbated respiratory disease","volume":"132","author":"Steinke","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.011_bib45","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2500\/aap.2007.28.3052","article-title":"Cytokine expression in peripheral blood lymphocytes before and after aspirin desensitization in aspirin-exacerbated respiratory disease","volume":"28","author":"Shome","year":"2007","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.iac.2016.06.011_bib46","doi-asserted-by":"crossref","first-page":"14590","DOI":"10.1016\/S0021-9258(18)82372-9","article-title":"Rapid phosphorylation and selective dephosphorylation of P-selectin accompanies platelet activation","volume":"268","author":"Crovello","year":"1993","journal-title":"J\u00a0Biol Chem"},{"issue":"12","key":"10.1016\/j.iac.2016.06.011_bib47","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1161\/ATVBAHA.110.207480","article-title":"Platelet-leukocyte interactions in cardiovascular disease and beyond","volume":"30","author":"Totani","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.iac.2016.06.011_bib48","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1182\/blood-2011-10-384826","article-title":"Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes","volume":"119","author":"Laidlaw","year":"2012","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.iac.2016.06.011_bib49","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jaci.2015.02.005","article-title":"Platelets in patients with aspirin-exacerbated respiratory disease","volume":"135","author":"Laidlaw","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"40","key":"10.1016\/j.iac.2016.06.011_bib50","doi-asserted-by":"crossref","first-page":"28264","DOI":"10.1074\/jbc.274.40.28264","article-title":"Differential metabolism of exogenous and endogenous arachidonic acid in human neutrophils","volume":"274","author":"Sala","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.iac.2016.06.011_bib51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1749-6632.1994.tb12038.x","article-title":"Leukotriene C4 formation by transcellular biosynthesis","volume":"714","author":"Maclouf","year":"1994","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.iac.2016.06.011_bib52","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1067\/mcp.2003.13","article-title":"Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease","volume":"73","author":"Klinkhardt","year":"2003","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.iac.2016.06.011_bib53","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1398-9995.2008.01658.x","article-title":"Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300\u00a0mg aspirin daily","volume":"63","author":"Rozsasi","year":"2008","journal-title":"Allergy"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985611630056X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985611630056X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T09:40:51Z","timestamp":1692524451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985611630056X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S088985611630056X"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2016.06.011","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms of Benefit with Aspirin Therapy in Aspirin-Exacerbated Respiratory Disease","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2016.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}